Skip to content
Advertisement

The overdose-reversal drug Narcan is displayed during training for employees of the Public Health Management Corporation (PHMC), Dec. 4, 2018, in Philadelphia. The U.S. Food and Drug Administration has approved selling the overdose antidote naloxone over-the-counter, Wednesday, March 29, 2023, marking the first time an opioid treatment drug will be available without a prescription. (AP Photo/Matt Rourke, File)

The overdose-reversal drug Narcan is displayed during training for employees of the Public Health Management Corporation (PHMC), Dec. 4, 2018, in Philadelphia. The U.S. Food and Drug Administration has approved selling the overdose antidote naloxone over-the-counter, Wednesday, March 29, 2023, marking the first time an opioid treatment drug will be available without a prescription. (AP Photo/Matt Rourke, File)

Featured Photo Galleries